Webinar: Reliable Fluid Biomarker Strategies for Clinical Neuroscience Research
Webinar Summary
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
As research into neurological diseases advances, fluid biomarkers derived from blood, cerebrospinal fluid, saliva, urine, and exosomes are opening new avenues for discovery and development. From neurofilaments and phosphorylated tau to glial fibrillary acidic protein, these biomarkers enable earlier disease detection and precise monitoring of therapeutic response, helping to accelerate clinical research. In this webinar, Yoav Noam, John Canfield, and John Allinson will discuss strategies to generate robust and reproducible biomarker data and the analytical considerations that support successful clinical studies.
Topics to be covered
- An automated immunoassay platform that improves assay sensitivity, dynamic range, and transferability for fluid biomarker measurement
- Analytical and reproducibility characterization of fluid biomarker immunoassays
- Importance of understanding assay performance and the requirement of in-study parallelism
- Benefits of leveraging industry partners to expedite study success
Up Next